Stiftelsen Helse og Rehabilitering   Report issue

Academic/Hospital Phase 4
Founded: Norway (1993)

Organization Overview

First Clinical Trial
2006
NCT00404079
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

glucosamine (1 trial)

Drugs in Other Trials (4)

ethanol (1 trial)

gluten (1 trial)

oxygen (1 trial)

zopiclone (Zimovane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 4)

Low Back Pain (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5